Impiego di un’associazione fissa di formoterolo e

Authors: Carlo Lucioni M Mangrella S Mazzi C Negrini A Vaghi

Publish Date: 2013/02/27

Volume: 4, Issue: 1, Pages: 15-23

PDF Link

Abstract

B/F was compared 1 with the free association of budesonide and formoterol based on Swedish clinical data derived from the COMSAFE trial an international open randomised controlled study Resources use and loss of productivity were evaluated by means of costs and tariffs from the Italian healthcare and economic systems 2 with fluticasone on the basis of data from another international randomised double blind double dummy study In this case too costs and tariffs applied were the ones current in ItalyTreatment with B/F resulted more convenient in terms of costs saved versus treatment with either budesonide and formoterol in two separate inhalers or fluticasone Average total direct and indirect costs saved by using B/F compared with budesonide and formoterol in separate inhalers were € 119 for each patient treated for 6 months € 130 were saved 40 of which being medical costs when one patient was treated with B/F instead of fluticasone over a period of 12 weeks

Keywords: